HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
Ryan Allway August 25th, 2021 Psychedelics The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )